Jump Financial, LLC Chroma Dex Corp. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.51 - $3.8 $64,002 - $96,896	-25,499 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$2.44 - $4.32 $62,217 - $110,155	25,499 New	25,499 $69,000
Q2 2022 Aug 09, 2022	SELL	$1.59 - $2.7 $75,843 - $128,790	-47,700 Reduced 72.6%	18,000 $30,000
Q1 2022 May 12, 2022	BUY	$2.02 - $3.92 $54,136 - $105,056	26,800 Added 68.89%	65,700 $162,000
Q4 2021 Feb 10, 2022	SELL	$3.74 - $6.7 $19,044 - $34,116	-5,092 Reduced 11.57%	38,900 $145,000
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.41 $26,571 - $45,720	4,392 Added 11.09%	43,992 $275,000
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $106,560 - $174,720	16,000 Added 67.8%	39,600 $390,000
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $108,324 - $442,263	23,600 New	23,600 $220,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.